(Q44432093)

2 December 2017

Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway (English)

1 reference

2 December 2017

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway (English)

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

31 December 2023

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

nerve tissue proteins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

31 December 2023

12

David T Curiel

1 reference

2 December 2017

1

Juan Fueyo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

Candelaria Gomez-Manzano

3

object named as

Candelaria Gomez-Manzano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

author name string

Ramon Alemany

2

1 reference

2 December 2017

Asadullah Khan

5

1 reference

2 December 2017

Ta-Jen Liu

7

1 reference

2 December 2017

Hong Jiang

8

1 reference

2 December 2017

Kaori Suzuki

10

1 reference

2 December 2017

Raymond Sawaya

11

1 reference

2 December 2017

Gregory N. Fuller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

Charles A. Conrad

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

Michael G. Lemoine

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

W. K Alfred Yung

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

Frederick F. Lang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

7 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12734316

Journal of the National Cancer Institute

31 December 2023

published in

1 reference

2 December 2017

95

1 reference

2 December 2017

652-660

1 reference

2 December 2017

9

1 reference

Malignant glioma: genetics and biology of a grave matter.

2 December 2017

1

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

The INK4a/ARF network in tumour suppression

31 December 2023

2

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Cellular targets for transformation by the adenovirus E1A proteins

31 December 2023

3

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

31 December 2023

4

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

31 December 2023

5

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Targeted adenoviral vectors

31 December 2023

6

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

31 December 2023

7

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Biotechnology (Reading, Mass.)

31 December 2023

8

13

265

1995

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Alpha v integrins as receptors for tumor targeting by circulating ligands.

31 December 2023

9

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells

31 December 2023

11

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo

31 December 2023

13

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Suppression of human glioma growth by adenovirus-mediated Rb gene transfer

31 December 2023

14

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis.

31 December 2023

15

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

An implantable guide-screw system for brain tumor studies in small animals.

31 December 2023

16

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Xylene-free method for histological preparation: a multicentre evaluation

31 December 2023

18

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Nonparametric Estimation from Incomplete Observations

31 December 2023

19

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Replicative adenoviruses for cancer therapy

31 December 2023

21

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

31 December 2023

22

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization.

31 December 2023

24

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

31 December 2023

Targeting adenovirus

25

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions

31 December 2023

26

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

31 December 2023

27

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy

31 December 2023

28

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

31 December 2023

29

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ

31 December 2023

32

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Blood clearance rates of adenovirus type 5 in mice

31 December 2023

33

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

31 December 2023

34

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies.

31 December 2023

35

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

31 December 2023

Identifiers

1 reference

2 December 2017

1 reference